Home/Filings/4/0001127602-24-016175
4//SEC Filing

Strong Stewart W 4

Accession 0001127602-24-016175

CIK 0000313143other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 6:01 PM ET

Size

16.1 KB

Accession

0001127602-24-016175

Insider Transaction Report

Form 4
Period: 2024-05-17
Strong Stewart W
President, Global Hospital
Transactions
  • Tax Payment

    Common Stock

    2024-05-17$95.73/sh284$27,18715,324 total
  • Award

    Non-qualified Stock Option (Right to Buy)

    2024-05-17+6,3136,313 total
    Exercise: $95.73Exp: 2031-05-17Common Stock (6,313 underlying)
  • Tax Payment

    Common Stock

    2024-05-20$95.08/sh1,555$147,84918,882 total
  • Award

    Common Stock

    2024-05-17+2,87218,196 total
  • Exercise/Conversion

    Common Stock

    2024-05-20$56.57/sh+2,241$126,77320,437 total
  • Sale

    Common Stock

    2024-05-20$95.11/sh686$65,24518,196 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-05-202,2412,242 total
    Exercise: $56.57From: 2023-05-18Exp: 2028-05-18Common Stock (2,241 underlying)
Footnotes (8)
  • [F1]Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
  • [F2]This number includes unvested RSUs previously reported.
  • [F3]The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
  • [F4]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
  • [F5]Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).
  • [F6]Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
  • [F7]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
  • [F8]Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001420910

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:01 PM ET
Size
16.1 KB